More Than Weight Loss: How GLP-1 Medications Are Reshaping Whole-Body Health
GLP-1 medications entered the public conversation as weight loss drugs, and that reputation is well earned. But framing semaglutide and tirzepatide as appetite tools alone misses the bigger and far more exciting story unfolding in clinical research. Over the past two years, regulators have approved these medications for heart disease, kidney disease, sleep apnea, and […]
More Than Weight Loss: How GLP-1 Medications Are Reshaping Whole-Body Health Read More »









